188 related articles for article (PubMed ID: 26512603)
1. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder.
Liang Y; Zhao G; Sun R; Mao Y; Li G; Chen X; Gao L; Hu Z
J Affect Disord; 2015 Sep; 183():295-9. PubMed ID: 26047307
[TBL] [Abstract][Full Text] [Related]
3. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in the promoters of let-7 are associated with the risk and age at onset of ischemic stroke: A case control study.
Wang Y; Qiu L; Jiang W; Chen M; He Z; Wang Y; Deng S
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):106998. PubMed ID: 36780761
[TBL] [Abstract][Full Text] [Related]
6. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
7. Association between functional polymorphisms in the flanking region of miR-143/145 and risk of papillary thyroid carcinoma: A case-control study.
Wang Y; Zhou S; Zhao W; Li Z; Zhu J; Wei T; Song H
Medicine (Baltimore); 2020 Dec; 99(49):e23560. PubMed ID: 33285775
[TBL] [Abstract][Full Text] [Related]
8. Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma.
Liu J; Ni S
Gene; 2018 Feb; 642():256-260. PubMed ID: 29154871
[TBL] [Abstract][Full Text] [Related]
9. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
10. An rs13293512 polymorphism in the promoter of let-7 is associated with a reduced risk of ischemic stroke.
Zhang L; Yang J; Xue Q; Yang D; Lu Y; Guang X; Zhang W; Ba R; Zhu H; Ma X
J Thromb Thrombolysis; 2016 Nov; 42(4):610-5. PubMed ID: 27530126
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant rs13293512 in the promoter of let-7 is associated with an increased risk of breast cancer in Chinese women.
Sun R; Gong J; Li J; Ruan Z; Yang X; Zheng Y; Qing L; He X; Jiang J; Peng Y; Zou H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028134
[TBL] [Abstract][Full Text] [Related]
12. Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.
Gao Y; Chen F; Niu S; Lin S; Li S
Medicine (Baltimore); 2015 Sep; 94(36):e1246. PubMed ID: 26356687
[TBL] [Abstract][Full Text] [Related]
13. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
14. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
15. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
16. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
Kwon KH; Lee YC; Chung JH; Eun YG
J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
[TBL] [Abstract][Full Text] [Related]
17. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
[TBL] [Abstract][Full Text] [Related]
18. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
19. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
20. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
Su X; Lin LW; Weng JL; Chen SW; Yang XH; Zhou DL; Long YK; Shao Q; Ye ZL; Peng JL; Deng L; He CY; Yang AK
Cancer Biomark; 2019; 26(4):461-470. PubMed ID: 31658048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
